One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
Introduction and Application of Microarray ChipJune 20, 20221. Definition of Microarray ChipMicroarray chip refers to the use of light-guided in-situ synthesis or micro-spotting methods to solidify a large number of biological macromolecules such as nucleic ac...view
The Impact of DNA Genome Sequencing on Cancer Research and TreatmentJuly 18, 2024Cancer remains one of the most formidable challenges in medical science. As we continually seek innovative solutions to understand and combat this complex disease, DNA genome sequencing has proven to ...view
What is IVF Preimplantation Genetic Testing (PGT)?June 20, 20221. What is Preimplantation Genetic Testing (PGT)?Preimplantation genetic testing (PGT) is a method of screening some cells from an embryo and detecting related genetic and chromosomal disorders. This ...view